CLINICAL_TRIALS
trial_result
· 2012-02-13
Clinical Trial Update: A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas [Phase 2]
Summary
A Phase II trial evaluating pegylated interferon alfa-2b in pediatric diffuse intrinsic pontine glioma has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Diffuse Intrinsic Pontine Glioma | Phase 2 | Status: COMPLETED | Results posted: 2012-02-13